Eintrag weiter verarbeiten
Stem Cell-Induced Inflammation in Cholesteatoma Is Inhibited by the TLR4 Antagonist LPS-RS
Gespeichert in:
| Zeitschriftentitel: | Cells |
|---|---|
| Personen und Körperschaften: | , , , , , , |
| In: | Cells, 9, 2020, 1, S. 199 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
MDPI AG
|
| Schlagwörter: |
| author_facet |
Schürmann, Matthias Greiner, Johannes F. W. Volland-Thurn, Verena Oppel, Felix Kaltschmidt, Christian Sudhoff, Holger Kaltschmidt, Barbara Schürmann, Matthias Greiner, Johannes F. W. Volland-Thurn, Verena Oppel, Felix Kaltschmidt, Christian Sudhoff, Holger Kaltschmidt, Barbara |
|---|---|
| author |
Schürmann, Matthias Greiner, Johannes F. W. Volland-Thurn, Verena Oppel, Felix Kaltschmidt, Christian Sudhoff, Holger Kaltschmidt, Barbara |
| spellingShingle |
Schürmann, Matthias Greiner, Johannes F. W. Volland-Thurn, Verena Oppel, Felix Kaltschmidt, Christian Sudhoff, Holger Kaltschmidt, Barbara Cells Stem Cell-Induced Inflammation in Cholesteatoma Is Inhibited by the TLR4 Antagonist LPS-RS General Medicine |
| author_sort |
schürmann, matthias |
| spelling |
Schürmann, Matthias Greiner, Johannes F. W. Volland-Thurn, Verena Oppel, Felix Kaltschmidt, Christian Sudhoff, Holger Kaltschmidt, Barbara 2073-4409 MDPI AG General Medicine http://dx.doi.org/10.3390/cells9010199 <jats:p>Cholesteatoma is a severe non-cancerous lesion of the middle ear characterized by massive inflammation, tissue destruction, and an abnormal growth of keratinized squamous epithelium. We recently demonstrated the presence of pathogenic stem cells within cholesteatoma tissue, unfortunately their potential roles in regulating disease-specific chronic inflammation remain poorly understood. In the presented study, we utilized our established human in vitro cholesteatoma stem cell model for treatments with lipopolysaccharides (LPS), tumor necrosis factor α (TNFα), and the TLR4-antagonist LPS from R. sphaeroides (LPS-RS) followed by qPCR, western blot, and immunocytochemistry. Middle ear cholesteatoma stem cells (ME-CSCs) showed a significantly increased expression of TLR4 accompanied by a significantly enhanced LPS-dependent pro-inflammatory gene expression pattern of TNFα, IL-1α, IL-1ß, IL-6, and IL-8 compared to non-pathogenic control cells. LPS-dependent pro-inflammatory gene expression in ME-CSCs was driven by an enhanced activity of NF-κB p65 leading to a TNFα-mediated feed-forward-loop of pro-inflammatory NF-κB target gene expression. Functional inactivation of TLR4 via the TLR4-antagonist LPS-RS blocked chronic inflammation in ME-CSCs, resulting in a nearly complete loss of IL-1ß, IL-6, and TNFα expression. In summary, we determined that ME-CSCs mediate the inflammatory environment of cholesteatoma via TLR4-mediated NF-κB-signaling, suggesting a distinct role of ME-CSCs as drivers of cholesteatoma progression and TLR4 on ME-CSCs as a therapeutic target.</jats:p> Stem Cell-Induced Inflammation in Cholesteatoma Is Inhibited by the TLR4 Antagonist LPS-RS Cells |
| doi_str_mv |
10.3390/cells9010199 |
| facet_avail |
Online Free |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM5MC9jZWxsczkwMTAxOTk |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM5MC9jZWxsczkwMTAxOTk |
| institution |
DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 |
| imprint |
MDPI AG, 2020 |
| imprint_str_mv |
MDPI AG, 2020 |
| issn |
2073-4409 |
| issn_str_mv |
2073-4409 |
| language |
English |
| mega_collection |
MDPI AG (CrossRef) |
| match_str |
schurmann2020stemcellinducedinflammationincholesteatomaisinhibitedbythetlr4antagonistlpsrs |
| publishDateSort |
2020 |
| publisher |
MDPI AG |
| recordtype |
ai |
| record_format |
ai |
| series |
Cells |
| source_id |
49 |
| title |
Stem Cell-Induced Inflammation in Cholesteatoma Is Inhibited by the TLR4 Antagonist LPS-RS |
| title_unstemmed |
Stem Cell-Induced Inflammation in Cholesteatoma Is Inhibited by the TLR4 Antagonist LPS-RS |
| title_full |
Stem Cell-Induced Inflammation in Cholesteatoma Is Inhibited by the TLR4 Antagonist LPS-RS |
| title_fullStr |
Stem Cell-Induced Inflammation in Cholesteatoma Is Inhibited by the TLR4 Antagonist LPS-RS |
| title_full_unstemmed |
Stem Cell-Induced Inflammation in Cholesteatoma Is Inhibited by the TLR4 Antagonist LPS-RS |
| title_short |
Stem Cell-Induced Inflammation in Cholesteatoma Is Inhibited by the TLR4 Antagonist LPS-RS |
| title_sort |
stem cell-induced inflammation in cholesteatoma is inhibited by the tlr4 antagonist lps-rs |
| topic |
General Medicine |
| url |
http://dx.doi.org/10.3390/cells9010199 |
| publishDate |
2020 |
| physical |
199 |
| description |
<jats:p>Cholesteatoma is a severe non-cancerous lesion of the middle ear characterized by massive inflammation, tissue destruction, and an abnormal growth of keratinized squamous epithelium. We recently demonstrated the presence of pathogenic stem cells within cholesteatoma tissue, unfortunately their potential roles in regulating disease-specific chronic inflammation remain poorly understood. In the presented study, we utilized our established human in vitro cholesteatoma stem cell model for treatments with lipopolysaccharides (LPS), tumor necrosis factor α (TNFα), and the TLR4-antagonist LPS from R. sphaeroides (LPS-RS) followed by qPCR, western blot, and immunocytochemistry. Middle ear cholesteatoma stem cells (ME-CSCs) showed a significantly increased expression of TLR4 accompanied by a significantly enhanced LPS-dependent pro-inflammatory gene expression pattern of TNFα, IL-1α, IL-1ß, IL-6, and IL-8 compared to non-pathogenic control cells. LPS-dependent pro-inflammatory gene expression in ME-CSCs was driven by an enhanced activity of NF-κB p65 leading to a TNFα-mediated feed-forward-loop of pro-inflammatory NF-κB target gene expression. Functional inactivation of TLR4 via the TLR4-antagonist LPS-RS blocked chronic inflammation in ME-CSCs, resulting in a nearly complete loss of IL-1ß, IL-6, and TNFα expression. In summary, we determined that ME-CSCs mediate the inflammatory environment of cholesteatoma via TLR4-mediated NF-κB-signaling, suggesting a distinct role of ME-CSCs as drivers of cholesteatoma progression and TLR4 on ME-CSCs as a therapeutic target.</jats:p> |
| container_issue |
1 |
| container_start_page |
0 |
| container_title |
Cells |
| container_volume |
9 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792341345965178893 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T16:18:26.651Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Stem+Cell-Induced+Inflammation+in+Cholesteatoma+Is+Inhibited+by+the+TLR4+Antagonist+LPS-RS&rft.date=2020-01-14&genre=article&issn=2073-4409&volume=9&issue=1&pages=199&jtitle=Cells&atitle=Stem+Cell-Induced+Inflammation+in+Cholesteatoma+Is+Inhibited+by+the+TLR4+Antagonist+LPS-RS&aulast=Kaltschmidt&aufirst=Barbara&rft_id=info%3Adoi%2F10.3390%2Fcells9010199&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792341345965178893 |
| author | Schürmann, Matthias, Greiner, Johannes F. W., Volland-Thurn, Verena, Oppel, Felix, Kaltschmidt, Christian, Sudhoff, Holger, Kaltschmidt, Barbara |
| author_facet | Schürmann, Matthias, Greiner, Johannes F. W., Volland-Thurn, Verena, Oppel, Felix, Kaltschmidt, Christian, Sudhoff, Holger, Kaltschmidt, Barbara, Schürmann, Matthias, Greiner, Johannes F. W., Volland-Thurn, Verena, Oppel, Felix, Kaltschmidt, Christian, Sudhoff, Holger, Kaltschmidt, Barbara |
| author_sort | schürmann, matthias |
| container_issue | 1 |
| container_start_page | 0 |
| container_title | Cells |
| container_volume | 9 |
| description | <jats:p>Cholesteatoma is a severe non-cancerous lesion of the middle ear characterized by massive inflammation, tissue destruction, and an abnormal growth of keratinized squamous epithelium. We recently demonstrated the presence of pathogenic stem cells within cholesteatoma tissue, unfortunately their potential roles in regulating disease-specific chronic inflammation remain poorly understood. In the presented study, we utilized our established human in vitro cholesteatoma stem cell model for treatments with lipopolysaccharides (LPS), tumor necrosis factor α (TNFα), and the TLR4-antagonist LPS from R. sphaeroides (LPS-RS) followed by qPCR, western blot, and immunocytochemistry. Middle ear cholesteatoma stem cells (ME-CSCs) showed a significantly increased expression of TLR4 accompanied by a significantly enhanced LPS-dependent pro-inflammatory gene expression pattern of TNFα, IL-1α, IL-1ß, IL-6, and IL-8 compared to non-pathogenic control cells. LPS-dependent pro-inflammatory gene expression in ME-CSCs was driven by an enhanced activity of NF-κB p65 leading to a TNFα-mediated feed-forward-loop of pro-inflammatory NF-κB target gene expression. Functional inactivation of TLR4 via the TLR4-antagonist LPS-RS blocked chronic inflammation in ME-CSCs, resulting in a nearly complete loss of IL-1ß, IL-6, and TNFα expression. In summary, we determined that ME-CSCs mediate the inflammatory environment of cholesteatoma via TLR4-mediated NF-κB-signaling, suggesting a distinct role of ME-CSCs as drivers of cholesteatoma progression and TLR4 on ME-CSCs as a therapeutic target.</jats:p> |
| doi_str_mv | 10.3390/cells9010199 |
| facet_avail | Online, Free |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM5MC9jZWxsczkwMTAxOTk |
| imprint | MDPI AG, 2020 |
| imprint_str_mv | MDPI AG, 2020 |
| institution | DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1 |
| issn | 2073-4409 |
| issn_str_mv | 2073-4409 |
| language | English |
| last_indexed | 2024-03-01T16:18:26.651Z |
| match_str | schurmann2020stemcellinducedinflammationincholesteatomaisinhibitedbythetlr4antagonistlpsrs |
| mega_collection | MDPI AG (CrossRef) |
| physical | 199 |
| publishDate | 2020 |
| publishDateSort | 2020 |
| publisher | MDPI AG |
| record_format | ai |
| recordtype | ai |
| series | Cells |
| source_id | 49 |
| spelling | Schürmann, Matthias Greiner, Johannes F. W. Volland-Thurn, Verena Oppel, Felix Kaltschmidt, Christian Sudhoff, Holger Kaltschmidt, Barbara 2073-4409 MDPI AG General Medicine http://dx.doi.org/10.3390/cells9010199 <jats:p>Cholesteatoma is a severe non-cancerous lesion of the middle ear characterized by massive inflammation, tissue destruction, and an abnormal growth of keratinized squamous epithelium. We recently demonstrated the presence of pathogenic stem cells within cholesteatoma tissue, unfortunately their potential roles in regulating disease-specific chronic inflammation remain poorly understood. In the presented study, we utilized our established human in vitro cholesteatoma stem cell model for treatments with lipopolysaccharides (LPS), tumor necrosis factor α (TNFα), and the TLR4-antagonist LPS from R. sphaeroides (LPS-RS) followed by qPCR, western blot, and immunocytochemistry. Middle ear cholesteatoma stem cells (ME-CSCs) showed a significantly increased expression of TLR4 accompanied by a significantly enhanced LPS-dependent pro-inflammatory gene expression pattern of TNFα, IL-1α, IL-1ß, IL-6, and IL-8 compared to non-pathogenic control cells. LPS-dependent pro-inflammatory gene expression in ME-CSCs was driven by an enhanced activity of NF-κB p65 leading to a TNFα-mediated feed-forward-loop of pro-inflammatory NF-κB target gene expression. Functional inactivation of TLR4 via the TLR4-antagonist LPS-RS blocked chronic inflammation in ME-CSCs, resulting in a nearly complete loss of IL-1ß, IL-6, and TNFα expression. In summary, we determined that ME-CSCs mediate the inflammatory environment of cholesteatoma via TLR4-mediated NF-κB-signaling, suggesting a distinct role of ME-CSCs as drivers of cholesteatoma progression and TLR4 on ME-CSCs as a therapeutic target.</jats:p> Stem Cell-Induced Inflammation in Cholesteatoma Is Inhibited by the TLR4 Antagonist LPS-RS Cells |
| spellingShingle | Schürmann, Matthias, Greiner, Johannes F. W., Volland-Thurn, Verena, Oppel, Felix, Kaltschmidt, Christian, Sudhoff, Holger, Kaltschmidt, Barbara, Cells, Stem Cell-Induced Inflammation in Cholesteatoma Is Inhibited by the TLR4 Antagonist LPS-RS, General Medicine |
| title | Stem Cell-Induced Inflammation in Cholesteatoma Is Inhibited by the TLR4 Antagonist LPS-RS |
| title_full | Stem Cell-Induced Inflammation in Cholesteatoma Is Inhibited by the TLR4 Antagonist LPS-RS |
| title_fullStr | Stem Cell-Induced Inflammation in Cholesteatoma Is Inhibited by the TLR4 Antagonist LPS-RS |
| title_full_unstemmed | Stem Cell-Induced Inflammation in Cholesteatoma Is Inhibited by the TLR4 Antagonist LPS-RS |
| title_short | Stem Cell-Induced Inflammation in Cholesteatoma Is Inhibited by the TLR4 Antagonist LPS-RS |
| title_sort | stem cell-induced inflammation in cholesteatoma is inhibited by the tlr4 antagonist lps-rs |
| title_unstemmed | Stem Cell-Induced Inflammation in Cholesteatoma Is Inhibited by the TLR4 Antagonist LPS-RS |
| topic | General Medicine |
| url | http://dx.doi.org/10.3390/cells9010199 |